Pharma Mar, S.A.

€65.40As of Sun 8 Nov 2026, 12:00 UTC
BME:PHMHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR 9.01%
Div yield 1.53%
ROE 31.47%
Biotechnology
Beta (5Y) 0.43
PE TTM 16.58
TSR TTM (9.69%)
Mkt cap €1.134B
ROIC 39.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€81
23.13%
(36.23%)
Hold 6|6|8|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.62
0.61
0.66
0.64
7.67%
(3.12%)
2.41%
0.94%
Revenue€M
81.28
84.87
83.48
87.78
5.10%
3.89%
3.10%
6.05%
Peers (US$1.273B)
Cap (US$)
PE
225.9M
—
115.7M
25.56x
Capital
TTM
5Y
10Y
Leveragex
0.503
(0.513)
(0.441)
EBIT/Intx
0.994
3.129
2.501
Own earn%
65.42
(78.73)
(74.81)
Sh yield%
18.61
17.73
20.65
Owners
Insiders/Inst%
9.28
44.45
Short interest%
3.77
SBC / revenue%
2.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
3